Prohibiting the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, health maintenance organizations, and managed care organizations from applying a prior authorization requirement, step therapy protocol, or fail-first protocol for a nonopioid drug used for the treatment of pain that is more restrictive than any prior authorization requirement, step therapy protocol, or fail-first protocol applied to an opioid or narcotic drug used for the treatment of pain; etc.